Skip to main content
Log in

Nizatidine and Cisapride Increase Salivary Secretion in Rats

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Saliva is a neurally induced solution with buffering capacity against acidic solutions. Salivation therefore plays an important role in defending the esophageal mucosa against refluxed gastric acid and is evoked by cholinergic stimulation. Both nizatidine and cisapride are reported to increase acetylcholine concentrations in the postganglionic cholinergic synapses. We performed this study to clarify the effect of administration of nizatidine and cisapride on salivary secretion. Eight-week-old male Sprague–Dawley rats were used for the experiments. Histamine-stimulated gastric acid secretion was measured after intraduodenal administration of nizatidine or famotidine to determine the equipotent acid-suppressing doses. Salivary secretion was then measured for 3 hr after intraduodenal administration of nizatidine (30 mg/kg), famotidine (3 mg/kg), or cisapride (1 mg/kg). Both nizatidine and famotidine dose-dependently inhibited histamine-stimulated gastric acid secretion. Total salivary secretion was significantly increased by nizatidine (P = 0.02) and cisapride (P = 0.02) but not by famotidine (P = 0.50) compared with controls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dodds WJ, Hogan WJ, Helm JF, Dent J: Pathogenesis of reflux esophagitis. Gastroenterology 81:376-394, 1981

    Google Scholar 

  2. Sonnenberg A, Steinkamp U, Weise A, Berges W, Wienbeck M, Rohner HG, Peter P. Salivary secretion in reflux esophagitis. Gastroenterology 83:889-895, 1982

    Google Scholar 

  3. Helm JF, Dodds WJ, Hogan WJ, Soergel KH, Egide MS, Wood CM: Acid neutralizing capacity of human saliva. Gastroenterology 83:69-74, 1982

    Google Scholar 

  4. Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC: Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 310:284-288, 1984

    Google Scholar 

  5. Helm JF, Dodds WJ, Hogan WJ: Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology 93:1393-1397, 1987

    Google Scholar 

  6. Korsten MA, Rosman AS, Fishbein S, Shlein RD, Goldberg HE, Biener A: Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med 90:701-706, 1991

    Google Scholar 

  7. Kao CH, Ho YJ, ChangLai SP, Liao KK: Evidence for decreased salivary function in patients with reflux esophagitis. Digestion 60:191-195, 1999

    Google Scholar 

  8. Mangos JA, McSherry NR, Nousia-Arvanitakis S, Irwin K: Handling of water and electrolytes by rabbit parotid and submaxillary glands. Am J Physiol 225:450-455, 1973

    Google Scholar 

  9. Beal AM: Parotid salivary flow and composition during infusion of acetylcholine and atropine into the carotid artery of conscious sodium-replete sheep. Q J Exp Physiol 64:89-107, 1979

    Google Scholar 

  10. Beal AM: Electrolyte composition of parotid saliva from sodium-replete red kangaroos (Macropus rufus). J Exp Biol 111:225-237, 1984

    Google Scholar 

  11. Kounenis G, Voutsas D, Koutsoviti-Papadopoulou M, Elezoglou V: Inhibition of acetylcholinesterase by the H2-receptor antagonist nizatidine. J Pharmacobio-Dyn 11:767-771, 1988

    Google Scholar 

  12. Ueki S, Seiki M, Yoneta T, Aita H, Chaki K, Hori Y, Morita H, Tagashira E, Itoh Z: Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats. J Pharmacol Exp Ther 264:152-157, 1993

    Google Scholar 

  13. Ueki S, Matsunaga Y, Yoneta T, Tamaki H, Itoh Z: Gastroprokinetic activity of nizatidine during the digestive state in the dog and rat. Arzneim-Forsch/Drug Res 49(II):618-625, 1999

    Google Scholar 

  14. Neya T, Itano N, Mizutani M, Yamasato T, Takaki M, Nakayama S: The effect of cisapride on neural 5-HT receptors in guinea-pig isolated ileum. Eur J Pharmacol 106:221-222, 1984

    Google Scholar 

  15. Tonini M, Galligan JJ, North RA: Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum. Gastroenterology 96:1257-1264, 1989

    Google Scholar 

  16. Van den Brink HW, Schuurkes JA, Van Nueten JM, Van Rossum JM: R 50 595, a selective non-competitive antagonist of cisapride, BRL 24924 and 5-hydroxytryptamine on the guinea-pig ileum. Eur J Pharmacol 181:119-125, 1990

    Google Scholar 

  17. Craig DA, Clarke DE: Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor. J Pharmacol Exp Ther 252:1378-1386, 1990

    Google Scholar 

  18. Taniyama K, Nakayama S, Takeda K, Matsuyama S, Shirakawa J, Sano I, Tanaka C: Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J Pharmacol Exp Ther 258:1098-1104, 1991

    Google Scholar 

  19. Adachi K, Ono M, Kawamura A, Yuki M, Fujishiro H, Kinoshita Y: Nizatidine and cisapride enhance salivary secretion in humans. Aliment Pharmacol Ther 16:297-301, 2002

    Google Scholar 

  20. Hiramatsu Y, Okabe S: Effect of intraduodenally administered histamine on gastric acid secretion in rats and guinea pigs. Dig Dis Sci 39:689-697, 1994

    Google Scholar 

  21. Lanzon-Miller S, Pounder RE, Hamilton MR, Ball S, Chronos NA, Raymond F, Olausson M, Cederberg C: Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1:239-351, 1987

    Google Scholar 

  22. Ruth M, Enbom H, Lundell L, Lonroth H, Sandberg N, Sandmark S: The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis. Scand J Gastroenterol 23:1141-1146, 1988

    Google Scholar 

  23. Bate CM, Keeling PW, O'Morain C, Wilkinson SP, Foster DN, Mountford RA, Temperley JM, Harvey RF, Thompson DG, Davis M, et al.: Comparison of omeprazole and cimetidine in reflux oesophatis: symptomatic, endoscopic, and histological evaluations. Gut 31:968-972, 1990

    Google Scholar 

  24. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH: Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. Gastroenterology 112:1798-1810, 1997

    Google Scholar 

  25. Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A, et al.: A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 333:1106-1110, 1995

    Google Scholar 

  26. Inauen W, Emde C, Weber B, Armstrong D, Bettschen HU, Huber T, Scheurer U, Blum AL, Halter F, Merki HS: Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: A 24 hour ambulatory combined pH and manometry study. Gut 34:1025-1031, 1993

    Google Scholar 

  27. Goldin GF, Marcinkiewicz M, Zbroch T, Bityutskiy LP, McCallum RW, Sarosiek J: Esophagoprotective potential of cisapride. An additional benefit for gastroesophageal reflux disease. Dig Dis Sci 42:1362-1369, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adachi, K., Furuta, K., Katsube, T. et al. Nizatidine and Cisapride Increase Salivary Secretion in Rats. Dig Dis Sci 49, 399–403 (2004). https://doi.org/10.1023/B:DDAS.0000020492.16088.28

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:DDAS.0000020492.16088.28

Navigation